The interplay between genetics, cognition and schizophrenia.

98–107. Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, et al. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet 2017; 390: 2481–9. Kutzelnigg A, Lassmann H. Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handbook Clin Neurol 2014; 122: 15–58. Nave KA, Werner HB. Myelination of the nervous system: mechanisms and functions. Ann Rev Cell Dev Biol 2014; 30: 503–33. Plemel JR, Liu WQ, Yong VW. Remyelination therapies: a new direction and challenge in multiple sclerosis. Nat Rev Drug Discov 2017; 16: 617–34. Raftopoulos R, Hickman SJ, Toosy A, Sharrack B, Mallik S, Paling D, et al. Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol 2016; 15: 259–69. Stassart RM, Mobius W, Nave KA, Edgar JM. The axon-myelin unit in development and degenerative disease. Front Neurosci 2018; 12: 467. Suhs KW, Hein K, Sattler MB, Gorlitz A, Ciupka C, Scholz K, et al. A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. Ann Neurol 2012; 72: 199–210. You Y, Joseph C, Wang C, Gupta V, Liu S, Yiannikas C, et al. Demyelination precedes axonal loss in the transneuronal spread of human neurodegenerative disease. Brain 2019; 142: 426–42.

• Publication year

  2019

• Venue

  Brain : a journal of neurology

• Publication date

  2019-01-29

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/brain/awy345PMID 30698760PMCID PMC6351778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polygenic risk score increases schizophrenia liability through cognition-relevant pathways

  2018cited by this paper
• Analysis of shared heritability in common disorders of the brain

  2018cited by this paper
• Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses

  2018cited by this paper
• Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders

  2018cited by this paper
• Analysis of shared heritability in common disorders of the brain

  2018cited by this paper
• Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register.

  2017cited by this paper
• A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains

  2017cited by this paper
• Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia

  2016cited by this paper
• Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

  2016cited by this paper
• Research review: Polygenic methods and their application to psychiatric traits.

  2014cited by this paper
• Biological Insights From 108 Schizophrenia-Associated Genetic Loci

  2014cited by this paper
• Molecular Genetic Evidence for Genetic Overlap between General Cognitive Ability and Risk for Schizophrenia: A Report from the Cognitive Genomics Consortium (COGENT)

  2013cited by this paper
• Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

  2009cited by this paper
• Edinburgh Research Explorer Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence

  year unknowncited by this paper

• The independent role of fine particulate matter and genetic liability on cognition in older adults

  2025cites this paper
• Neural fingerprints of data driven cognitive subtypes across the psychosis spectrum: a B-SNIP study

  2025cites this paper
• Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach.

  2024cites this paper
• Correlation of abnormalities in resting state fMRI with executive functioning in chronic schizophrenia.

  2021cites this paper
• Oxidative Stress Biomarkers as a Predictor of Stage Illness and Clinical Course of Schizophrenia

  2021cites this paper
• S0033291720005413jra 1..9

  2021cites this paper
• Genetic Variations in Evolutionary Accelerated Regions Disrupt Cognition in Schizophrenia

  2021cites this paper
• Striatal dopamine D2/3 receptors in medication-naïve schizophrenia: an [123I] IBZM SPECT study

  2021cites this paper
• Transcriptome-wide association study reveals two genes that influence mismatch negativity

  2020cites this paper
• Genetically, Developmentally, and Clinically Distinct Cognitive Subtypes in Schizophrenia: A Tale of Three Trajectories.

  2020cites this paper
• Evidence of association of the DISC1 interactome gene set with schizophrenia from GWAS.

  2019cites this paper
• Striatal dopamine D 2

  year unknowncites this paper